Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia; the study is currently active but not recruiting. Spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• Ropeginterferon alfa-2b (ropeginterferon alfa-2b)

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Essential Thrombocythaemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING